Loading…

Ginkgo Bioworks (DNA) backlog: remaining performance obligations

How much revenue Ginkgo Bioworks already has under contract, how fast it converts, and who it is with.

Data as of .

Ginkgo Bioworks backlog history

$0$200M$400MSep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Jun 2026Backlog (RPO)Trailing 12-month revenue
Remaining performance obligations at each quarter end (bars) against trailing twelve-month revenue (line).
Amounts in USD. Source: SEC XBRL filings.
Quarter endBacklog (RPO)TTM revenueCoverageCustomer prepayments
30 Jun 2026$113M$132M0.9 yrs$13.2M
31 Mar 2026$127M$151M0.8 yrs$14.9M
31 Dec 2025$137M$170M0.8 yrs$94.1M
30 Sep 2025$81.3M$160M0.5 yrs$25.2M
30 Jun 2025$102M$210M0.5 yrs$28.3M
31 Mar 2025$124M$227M0.5 yrs$33.7M
31 Dec 2024$85.8M$227M0.4 yrs$126M
30 Sep 2024$68.0M$218M0.3 yrs$22.9M
30 Jun 2024$76.8M$184M0.4 yrs$26.0M
31 Mar 2024$96.9M$209M0.5 yrs$33.6M
31 Dec 2023$110M$252M0.4 yrs$202M
30 Sep 2023$117M$315M0.4 yrsn/a

Questions

What is Ginkgo Bioworks's backlog?
Ginkgo Bioworks reported $113M of remaining performance obligations at 30 Jun 2026, up 11% from a year earlier and down 11% from the previous quarter. That is 0.9 years of trailing revenue already under contract. Book-to-bill last quarter: 0.29.
How fast does Ginkgo Bioworks's backlog turn into revenue?
Over the last twelve months Ginkgo Bioworks recognised revenue equal to about 135% of the backlog it started each quarter with.

About these numbers

Remaining performance obligations (RPO) are revenue a company has contracted but not yet recognised, as reported in its SEC filings (XBRL tag RevenueRemainingPerformanceObligation). Coverage = backlog ÷ trailing twelve-month revenue. Book-to-bill = (change in backlog + revenue) ÷ revenue. Conversion = revenue recognised ÷ the backlog at the start of each quarter, summed over four quarters. Counterparty values come from company filings and releases.